Suraksha Diagnostic Limited has filed its quarterly compliance certificate with stock exchanges for the quarter ended March 31, 2026. The certificate, issued under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, was submitted to both BSE Limited and The National Stock Exchange of India Limited on April 06, 2026.

Regulatory Compliance Certificate

The certificate was issued by KFin Technologies Limited, which serves as the Registrar and Share Transfer Agent for Suraksha Diagnostic Limited. KFin Technologies has its registered office at Selenium, Tower B, Plot No- 31 & 32, Financial District, Nanakramguda, Serilingampally, Rangareddi, Hyderabad-500032, Telangana.

Certificate Details

The certificate specifically states that no security certificate was received for dematerialization and/or rematerialization during the quarter ended March 31, 2026. This certification is a mandatory requirement under SEBI regulations for companies to report their share transfer activities through their registrar and transfer agents.

The certificate was signed by Ganesh Chandra Patro, Deputy Vice President at KFin Technologies Limited, and submitted to the exchanges by Mamta Jain, Company Secretary & Compliance Officer of Suraksha Diagnostic Limited.

Regulatory Framework

Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, requires registrar and transfer agents to provide quarterly certificates regarding the processing of security certificates for dematerialization and rematerialization. This ensures transparency in share transfer processes and maintains investor confidence in the securities market.

The filing demonstrates Suraksha Diagnostic Limited's commitment to regulatory compliance and transparent reporting practices. Such regular compliance filings are essential for maintaining good corporate governance standards and meeting stock exchange listing requirements.

Suraksha Diagnostic Limited has announced the resignation of its Group Chief Financial Officer (CFO) K S Ravindra, effective on or before 31 May 2026. The resignation was submitted on 02 March 2026, citing personal reasons as the primary factor behind his decision to step down from his role as Key Managerial Personnel (KMP).

Resignation Details and Timeline

The company received Ravindra's resignation letter on 02 March 2026, in which he formally tendered his resignation from the position of Group CFO. As per the terms of his appointment, he will serve a 3-month notice period, ensuring his last working day falls on or before 31 May 2026 at the close of business hours.

Regulatory Compliance and Disclosures

Suraksha Diagnostic has fulfilled its regulatory obligations by informing both BSE Limited and The National Stock Exchange of India Limited about this key managerial change. The intimation was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ensuring complete transparency with stakeholders.

The company has received confirmation from K S Ravindra that there are no material reasons for his resignation other than the personal reasons mentioned in his resignation letter. This confirmation provides clarity to investors and regulatory authorities about the nature of his departure.

Company's Response and Transition

Suraksha Diagnostic has placed on record its deep appreciation for the services rendered by K S Ravindra and acknowledged his valuable contributions during his tenure as Group CFO. The company emphasized that Ravindra has committed to extending his full cooperation to ensure a smooth transition of responsibilities during the notice period.

The resignation letter indicates that the departing CFO will work closely with the management to facilitate the handover process, maintaining operational continuity during this transition phase. The company has assured stakeholders that all necessary statutory and regulatory filings will be completed as required.

About the Resignation Process

Ravindra's resignation follows standard corporate governance practices, with proper documentation and regulatory compliance. His resignation letter, addressed to the Board of Directors, expressed gratitude for the opportunity and support extended during his tenure with the organization.

The company has made this information available on its website at www.surakshanet.com , ensuring transparency and accessibility for all stakeholders. This development represents a significant change in the company's key management personnel structure as it moves forward with succession planning.